• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, May 11, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

MicroMesh: a microscopic polymeric network to attack glioblastoma multiforme

Bioengineer by Bioengineer
April 19, 2021
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Researchers at Istituto Italiano di Tecnologia in collaboration with Stanford Medicine and the San Raffaele Hospital have demonstrated with preclinical studies the effectiveness of a new biomedical implant for the treatment of glioblastoma multiforme

IMAGE

Credit: D. Beghetto/IIT

Genova (Italy), 16th April 2021 – A micro-sized polymeric net wrapping around brain tumors, just like a fishing net around a shoal of fish: this is the microMESH, a new nanomedicine device capable to conform around the surface of tumor masses and efficiently deliver drugs. It has been described by the researchers of the IIT – Istituto Italiano di Tecnologia (Italian Institute of Technology) in Nature Nanotechnology. The new biomedical implant has been validated in preclinical studies that demonstrate its effectiveness for the treatment of glioblastoma multiforme.

This work has been carried out by the group of Prof. Paolo Decuzzi, head of the IIT Laboratory of Nanotechnology for Precision Medicine, in collaboration with the Neural Stem Cell Biology Laboratory of Dr. Rossella Galli at the San Raffaele Hospital in Milan and the group of Prof. Gerald Grant at the Lucile Packard Children’s Hospital of Stanford University. The study was originated within the research activities conducted by Decuzzi in the context of projects supported by the European Research Council and the Marie Sk?odowska-Curie Action program.

Although they are quite rare, brain tumors are among the most aggressive and difficult to cure. In particular, glioblastoma multiforme is the tumor with the most severe prognosis: the average survival is just over 12 months and only 5% of the patients survive beyond 5 years. Glioblastoma multiforme typically affects men and women between 45 and 75 years of age. Furthermore, unlike other malignancies, there has been no significant diagnostic and therapeutic improvements for this malignancy over the past 30 years. In fact, both the incidence of new cases and the number of deaths has remained practically unchanged. The only therapeutic strategy currently used is based on surgery, which consists of removing a part of the tumor mass and reducing intracranial pressure, followed by radiotherapy and/or chemotherapy.

The biomedical system developed by IIT and its collaborators can play a very important role in the fight against the disease, representing a possible effective alternative to the few pharmacological treatments used to date.

The microMESH has the shape of a micrometric polymeric net, it is made with biodegradable materials and wraps around the tumor mass. In fact, the micrometric thick polymeric fibers are very flexible and are arranged to form regular openings, which are also micrometric, just like the size of cancer cells. This unique feature allows the microMESH to achieve a closer interaction with the tumor mass, increasing the therapeutic efficacy. Its structure consists of two separate compartments in which different drugs can be loaded which are released towards the tumor mass in an independent, precise, and prolonged fashion. The microMESH can ‘attack’ glioblastoma by combining different therapies: chemotherapy, nanomedicine, and immunotherapy.

Prof. Paolo Decuzzi and his collaborators, in particular Daniele Di Mascolo and Anna Lisa Palange, will continue to develop the microMESH by integrating different types of drugs and therapies to tackle other types of tumors. In the short term, their major objective will be to validate the technology on glioblastoma patients.

###

Media Contact
Valeria delle Cave
[email protected]

Related Journal Article

http://dx.doi.org/10.1038/s41565-021-00879-3

Tags: cancerMedicine/HealthNanotechnology/MicromachinesResearch/DevelopmentTechnology Transfer
Share12Tweet8Share2ShareShareShare2

Related Posts

Miniature Sensor Uses Light to Detect Touch — Chemistry

Miniature Sensor Uses Light to Detect Touch

May 8, 2026
Iron Minerals Determine Whether Dissolved Organic Matter Fuels Microbes or Becomes Long-Term Carbon Storage — Chemistry

Iron Minerals Determine Whether Dissolved Organic Matter Fuels Microbes or Becomes Long-Term Carbon Storage

May 8, 2026

Kate Evans Appointed Associate Lab Director for Biological and Environmental Systems Science at ORNL

May 8, 2026

Advancing Multiscale Modeling and Overcoming Operational Challenges in Autothermal COâ‚‚-to-Methanol Reactors

May 8, 2026
Please login to join discussion

POPULAR NEWS

  • Research Indicates Potential Connection Between Prenatal Medication Exposure and Elevated Autism Risk

    840 shares
    Share 336 Tweet 210
  • New Study Reveals Plants Can Detect the Sound of Rain

    727 shares
    Share 290 Tweet 181
  • Salmonella Haem Blocks Macrophages, Boosts Infection

    61 shares
    Share 24 Tweet 15
  • Breastmilk Balances E. coli and Beneficial Bacteria in Infant Gut Microbiomes

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

New Post-Hoc Analysis Explores Daily Oral Orforglipron Use in Adults Over 65 with Obesity, Regardless of Diabetes Status

Evaluating Digoxin Use in Patients with Symptomatic Rheumatic Heart Disease

Evaluating the Effectiveness and Safety of Digitalis Glycosides in Treating Heart Failure

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.